MAPK10 and neurodegenerative disease: We believe that this novel scaffold, 5, 6-dihydroxy 3-alkyl-2-aryl-1-pyrimidinyl-1H-benzo[d]imidazole will be highly useful in the development of JNK3 selective inhibitors, as therapeutic agents for neurodegenerative diseases.